 | • レポートコード：20QY06-02991 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ヒトフィブリノーゲンのグローバル市場について種類別（純粋型ヒトフィブリノーゲン、フィブリノーゲン濃縮物（ヒト））、用途別（先天性フィブリノーゲン欠乏症、外科的処置）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ヒトフィブリノーゲン市場の概要 ・世界の主要地域別ヒトフィブリノーゲン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヒトフィブリノーゲン市場規模2015-2026：種類別（純粋型ヒトフィブリノーゲン、フィブリノーゲン濃縮物（ヒト）） ・世界のヒトフィブリノーゲン市場規模2015-2026：用途別（先天性フィブリノーゲン欠乏症、外科的処置） ・ヒトフィブリノーゲンの北米市場規模2015-2020 ・ヒトフィブリノーゲンのヨーロッパ市場規模2015-2020 ・ヒトフィブリノーゲンの中国市場規模2015-2020 ・ヒトフィブリノーゲンの日本市場規模2015-2020 ・ヒトフィブリノーゲンの東南アジア市場規模2015-2020 ・ヒトフィブリノーゲンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （CSL Behring、LFB、Shanghai RAAS、Boya、Hualan Biological Engineering、Harbin Pacific Biopharmaceutical、Greencross、Shanghai XinXing Medical） ・ヒトフィブリノーゲンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒトフィブリノーゲンの市場動向・機会・課題 ・調査の結論 |
Fibrinogen is a protein in the blood plasma that is essential for the coagulation of blood and is converted to fibrin by the action of thrombin in the presence of ionized calcium. Human fibrinogen is a protein which is important for blood clotting (coagulation).
The industry is concentration, the key brand include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, Greencross, Shanghai XinXing Medical and so on. Among them, CSL Behring and LFB are the leaders.
The leading companies own the advantages on better performance, more abundant product’s types, better technical and impeccable after-sales service. Consequently, they take the majority of the market share of high-end market. Looking to the future years, the slow downward price trend in recent years will maintain. As competition intensifies, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.
The industry is expected to remain innovation-led, with frequent acquisitions and strategic alliances adopted as the key strategies by the players to increase their industry presence. Market stays in mature period with a clear concentration. Meanwhile, optimize product mix and further develop value-added capabilities to maximize margins.
Significant and lasting barriers make entry into this market difficult. These barriers include, but are not to: (i) product development costs; (ii) capital requirements; (iii) intellectual property rights; (iv) regulatory requirement; and (v) Transitions’ unfair methods of competition.
Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this area, the future will still have more new investment enter the field. Even so, the market is intensely competitive .The study recommends the new entrants just having money but without technical advantage and upstream and downstream support do not to enter into this field.
Market Analysis and Insights: Global Human Fibrinogen Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Fibrinogen market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Human Fibrinogen industry.
Based on our recent survey, we have several different scenarios about the Human Fibrinogen YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 754 million in 2019. The market size of Human Fibrinogen will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Human Fibrinogen Scope and Market Size
The global Human Fibrinogen market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Fibrinogen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Human Fibrinogen market is segmented into
Pure Human Fibrinogen
Fibrinogen Concentrate (Human)
Segment by Application, the Human Fibrinogen market is segmented into
Congenital Fibrinogen Deficiency
Surgical Procedures
The Human Fibrinogen market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Fibrinogen market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Fibrinogen Market Share Analysis
Human Fibrinogen market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Fibrinogen business, the date to enter into the Human Fibrinogen market, Human Fibrinogen product introduction, recent developments, etc.
The major vendors covered:
CSL Behring
LFB
Shanghai RAAS
Boya
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Greencross
Shanghai XinXing Medical
1 Human Fibrinogen Market Overview
1.1 Human Fibrinogen Product Scope
1.2 Human Fibrinogen Segment by Type
1.2.1 Global Human Fibrinogen Sales by Type (2020-2026)
1.2.2 Pure Human Fibrinogen
1.2.3 Fibrinogen Concentrate (Human)
1.3 Human Fibrinogen Segment by Application
1.3.1 Global Human Fibrinogen Sales Comparison by Application (2020-2026)
1.3.2 Congenital Fibrinogen Deficiency
1.3.3 Surgical Procedures
1.4 Human Fibrinogen Market Estimates and Forecasts (2015-2026)
1.4.1 Global Human Fibrinogen Sales Growth Rate (2015-2026)
1.4.2 Global Human Fibrinogen Revenue and Growth Rate (2015-2026)
1.4.3 Global Human Fibrinogen Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Human Fibrinogen Industry Impact
1.5.1 How the Covid-19 is Affecting the Human Fibrinogen Industry
1.5.1.1 Human Fibrinogen Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Human Fibrinogen Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Human Fibrinogen Players to Combat Covid-19 Impact
2 Human Fibrinogen Estimate and Forecast by Region
2.1 Global Human Fibrinogen Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Human Fibrinogen Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Human Fibrinogen Sales Market Share by Region (2015-2020)
2.2.2 Global Human Fibrinogen Revenue Market Share by Region (2015-2020)
2.3 Global Human Fibrinogen Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Human Fibrinogen Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Human Fibrinogen Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Human Fibrinogen Estimates and Projections (2015-2026)
2.4.2 Europe Human Fibrinogen Estimates and Projections (2015-2026)
2.4.3 China Human Fibrinogen Estimates and Projections (2015-2026)
2.4.4 Japan Human Fibrinogen Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Human Fibrinogen Estimates and Projections (2015-2026)
2.4.6 India Human Fibrinogen Estimates and Projections (2015-2026)
3 Global Human Fibrinogen Competition Landscape by Players
3.1 Global Top Human Fibrinogen Players by Sales (2015-2020)
3.2 Global Top Human Fibrinogen Players by Revenue (2015-2020)
3.3 Global Human Fibrinogen Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Fibrinogen as of 2019)
3.4 Global Human Fibrinogen Average Price by Company (2015-2020)
3.5 Manufacturers Human Fibrinogen Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Human Fibrinogen Players (Opinion Leaders)
4 Global Human Fibrinogen Market Size by Type
4.1 Global Human Fibrinogen Historic Market Review by Type (2015-2020)
4.1.1 Global Human Fibrinogen Sales Market Share by Type (2015-2020)
4.1.2 Global Human Fibrinogen Revenue Market Share by Type (2015-2020)
4.1.3 Global Human Fibrinogen Price by Type (2014-2020)
4.2 Global Human Fibrinogen Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Human Fibrinogen Sales Forecast by Type (2021-2026)
4.2.2 Global Human Fibrinogen Revenue Forecast by Type (2021-2026)
4.2.3 Global Human Fibrinogen Price Forecast by Type (2021-2026)
5 Global Human Fibrinogen Market Size by Application
5.1 Global Human Fibrinogen Historic Market Review by Application (2015-2020)
5.1.1 Global Human Fibrinogen Sales Market Share by Application (2015-2020)
5.1.2 Global Human Fibrinogen Revenue Market Share by Application (2015-2020)
5.1.3 Global Human Fibrinogen Price by Application (2015-2020)
5.2 Global Human Fibrinogen Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Human Fibrinogen Sales Forecast by Application (2021-2026)
5.2.2 Global Human Fibrinogen Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Fibrinogen Price Forecast by Application (2021-2026)
3 North America Human Fibrinogen Market Facts & Figures
3.2 North America Human Fibrinogen Sales Market Share by Company (2015-2020)
3.3 North America Human Fibrinogen Sales Market Share by Type (2015-2020)
3.4 North America Human Fibrinogen Sales Market Share by Application (2015-2020)
4 Europe Human Fibrinogen Market Facts & Figures
4.2 Europe Human Fibrinogen Sales Market Share by Company (2015-2020)
4.3 Europe Human Fibrinogen Sales Market Share by Type (2015-2020)
4.4 Europe Human Fibrinogen Sales Market Share by Application (2015-2020)
5 China Human Fibrinogen Market Facts & Figures
5.2 China Human Fibrinogen Sales Market Share by Company (2015-2020)
5.3 China Human Fibrinogen Sales Market Share by Type (2015-2020)
5.4 China Human Fibrinogen Sales Market Share by Application (2015-2020)
6 Japan Human Fibrinogen Market Facts & Figures
6.2 Japan Human Fibrinogen Sales Market Share by Company (2015-2020)
6.3 Japan Human Fibrinogen Sales Market Share by Type (2015-2020)
6.4 Japan Human Fibrinogen Sales Market Share by Application (2015-2020)
7 Southeast Asia Human Fibrinogen Market Facts & Figures
7.2 Southeast Asia Human Fibrinogen Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Human Fibrinogen Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Human Fibrinogen Sales Market Share by Application (2015-2020)
8 India Human Fibrinogen Market Facts & Figures
8.2 India Human Fibrinogen Sales Market Share by Company (2015-2020)
8.3 India Human Fibrinogen Sales Market Share by Type (2015-2020)
8.4 India Human Fibrinogen Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Human Fibrinogen Business
12.1 CSL Behring
12.1.1 CSL Behring Human Fibrinogen Corporation Information
12.1.2 CSL Behring Human Fibrinogen Business Overview and Total Revenue
12.1.3 CSL Behring Human Fibrinogen Sales, Revenue and Gross Margin (2015-2020)
12.1.4 CSL Behring Human Fibrinogen Products Offered
12.1.5 CSL Behring Recent Development
12.2 LFB
12.2.1 LFB Human Fibrinogen Corporation Information
12.2.2 LFB Human Fibrinogen Business Overview and Total Revenue
12.2.3 LFB Human Fibrinogen Sales, Revenue and Gross Margin (2015-2020)
12.2.4 LFB Human Fibrinogen Products Offered
12.2.5 LFB Recent Development
12.3 Shanghai RAAS
12.3.1 Shanghai RAAS Human Fibrinogen Corporation Information
12.3.2 Shanghai RAAS Human Fibrinogen Business Overview and Total Revenue
12.3.3 Shanghai RAAS Human Fibrinogen Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Shanghai RAAS Human Fibrinogen Products Offered
12.3.5 Shanghai RAAS Recent Development
12.4 Boya
12.4.1 Boya Human Fibrinogen Corporation Information
12.4.2 Boya Human Fibrinogen Business Overview and Total Revenue
12.4.3 Boya Human Fibrinogen Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Boya Human Fibrinogen Products Offered
12.4.5 Boya Recent Development
12.5 Hualan Biological Engineering
12.5.1 Hualan Biological Engineering Human Fibrinogen Corporation Information
12.5.2 Hualan Biological Engineering Human Fibrinogen Business Overview and Total Revenue
12.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Hualan Biological Engineering Human Fibrinogen Products Offered
12.5.5 Hualan Biological Engineering Recent Development
12.6 Harbin Pacific Biopharmaceutical
12.6.1 Harbin Pacific Biopharmaceutical Human Fibrinogen Corporation Information
12.6.2 Harbin Pacific Biopharmaceutical Human Fibrinogen Business Overview and Total Revenue
12.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Products Offered
12.6.5 Harbin Pacific Biopharmaceutical Recent Development
12.7 Greencross
12.7.1 Greencross Human Fibrinogen Corporation Information
12.7.2 Greencross Human Fibrinogen Business Overview and Total Revenue
12.7.3 Greencross Human Fibrinogen Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Greencross Human Fibrinogen Products Offered
12.7.5 Greencross Recent Development
12.8 Shanghai XinXing Medical
12.8.1 Shanghai XinXing Medical Human Fibrinogen Corporation Information
12.8.2 Shanghai XinXing Medical Human Fibrinogen Business Overview and Total Revenue
12.8.3 Shanghai XinXing Medical Human Fibrinogen Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Shanghai XinXing Medical Human Fibrinogen Products Offered
12.8.5 Shanghai XinXing Medical Recent Development
13 Human Fibrinogen Manufacturing Cost Analysis
13.1 Human Fibrinogen Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Fibrinogen
13.4 Human Fibrinogen Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Fibrinogen Distributors List
14.3 Human Fibrinogen Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Human Fibrinogen Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Human Fibrinogen Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Human Fibrinogen Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Human Fibrinogen Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Human Fibrinogen Players to Combat Covid-19 Impact
Table 8. Global Market Human Fibrinogen Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Human Fibrinogen Sales (MT) by Region (2015-2020)
Table 10. Global Human Fibrinogen Sales Market Share by Region (2015-2020)
Table 11. Global Human Fibrinogen Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Human Fibrinogen Revenue Share by Region (2015-2020)
Table 13. Global Human Fibrinogen Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Human Fibrinogen Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Human Fibrinogen Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Human Fibrinogen Revenue Share Forecast by Region (2021-2026)
Table 17. Global Human Fibrinogen (MT) of Key Companies (2015-2020)
Table 18. Global Human Fibrinogen Sales Share by Company (2015-2020)
Table 19. Global Human Fibrinogen Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Human Fibrinogen Revenue Share by Company (2015-2020)
Table 21. Global Human Fibrinogen by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Fibrinogen as of 2019)
Table 22. Global Human Fibrinogen Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Human Fibrinogen Manufacturing Sites and Area Served
Table 24. Manufacturers Human Fibrinogen Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Human Fibrinogen Players
Table 27. Global Human Fibrinogen Sales (MT) by Type (2015-2020)
Table 28. Global Human Fibrinogen Sales Share by Type (2015-2020)
Table 29. Global Human Fibrinogen Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Human Fibrinogen Price (MT) by Type (2015-2020)
Table 31. Global Human Fibrinogen Sales Share by Type (2021-2026)
Table 32. Global Human Fibrinogen Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Human Fibrinogen Revenue Share by Type (2021-2026)
Table 34. Global Human Fibrinogen Price (MT) by Type (2021-2026)
Table 35. Global Human Fibrinogen Sales (MT) by Application (2015-2020)
Table 36. Global Human Fibrinogen Sales Share by Application (2015-2020)
Table 37. Global Human Fibrinogen Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Human Fibrinogen Price (MT) by Application (2015-2020)
Table 39. Global Human Fibrinogen Sales (MT) by Application (2021-2026)
Table 40. Global Human Fibrinogen Sales Share by Application (2021-2026)
Table 41. Global Human Fibrinogen Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Human Fibrinogen Revenue Share by Application (2021-2026)
Table 43. Global Human Fibrinogen Price (MT) by Application (2021-2026)
Table 44. United States Human Fibrinogen Sales (MT) by Company (2015-2020)
Table 45. United States Human Fibrinogen Sales Market Share by Company (2015-2020)
Table 46. United States Human Fibrinogen Sales (MT) by Type (2015-2020)
Table 47. United States Human Fibrinogen Sales Market Share by Type (2015-2020)
Table 48. United States Human Fibrinogen Sales (MT) by Application (2015-2020)
Table 49. United States Human Fibrinogen Sales Market Share by Application (2015-2020)
Table 50. Europe Human Fibrinogen Sales (MT) by Company (2015-2020)
Table 51. Europe Human Fibrinogen Sales Market Share by Company (2015-2020)
Table 52. Europe Human Fibrinogen Sales (MT) by Type (2015-2020)
Table 53. Europe Human Fibrinogen Sales Market Share by Type (2015-2020)
Table 54. Europe Human Fibrinogen Sales (MT) by Application (2015-2020)
Table 55. Europe Human Fibrinogen Sales Market Share by Type (2015-2020)
Table 56. China Human Fibrinogen Sales (MT) by Company (2015-2020)
Table 57. China Human Fibrinogen Sales Market Share by Company (2015-2020)
Table 58. China Human Fibrinogen Sales (MT) by Type (2015-2020)
Table 59. China Human Fibrinogen Sales Market Share by Type (2015-2020)
Table 60. China Human Fibrinogen Sales (MT) by Application (2015-2020)
Table 61. China Human Fibrinogen Sales Market Share by Application (2015-2020)
Table 62. Japan Human Fibrinogen Sales (MT) by Company (2015-2020)
Table 63. Japan Human Fibrinogen Sales Market Share by Company (2015-2020)
Table 64. Japan Human Fibrinogen Sales (MT) by Type (2015-2020)
Table 65. Japan Human Fibrinogen Sales Market Share by Type (2015-2020)
Table 66. Japan Human Fibrinogen Sales (MT) by Application (2015-2020)
Table 67. Japan Human Fibrinogen Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Human Fibrinogen Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Human Fibrinogen Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Human Fibrinogen Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Human Fibrinogen Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Human Fibrinogen Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Human Fibrinogen Sales Market Share by Application (2015-2020)
Table 74. India Human Fibrinogen Sales (MT) by Company (2015-2020)
Table 75. India Human Fibrinogen Sales Market Share by Company (2015-2020)
Table 76. India Human Fibrinogen Sales (MT) by Type (2015-2020)
Table 77. India Human Fibrinogen Sales Market Share by Type (2015-2020)
Table 78. India Human Fibrinogen Sales (MT) by Application (2015-2020)
Table 79. India Human Fibrinogen Sales Market Share by Application (2015-2020)
Table 80. CSL Behring Corporation Information
Table 81. CSL Behring Description and Business Overview
Table 82. CSL Behring Human Fibrinogen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. CSL Behring Human Fibrinogen Product
Table 84. CSL Behring Recent Development
Table 85. LFB Corporation Information
Table 86. LFB Description and Business Overview
Table 87. LFB Human Fibrinogen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. LFB Human Fibrinogen Product
Table 89. LFB Recent Development
Table 90. Shanghai RAAS Corporation Information
Table 91. Shanghai RAAS Description and Business Overview
Table 92. Shanghai RAAS Human Fibrinogen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Shanghai RAAS Human Fibrinogen Product
Table 94. Shanghai RAAS Recent Development
Table 95. Boya Corporation Information
Table 96. Boya Description and Business Overview
Table 97. Boya Human Fibrinogen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Boya Human Fibrinogen Product
Table 99. Boya Recent Development
Table 100. Hualan Biological Engineering Corporation Information
Table 101. Hualan Biological Engineering Description and Business Overview
Table 102. Hualan Biological Engineering Human Fibrinogen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Hualan Biological Engineering Human Fibrinogen Product
Table 104. Hualan Biological Engineering Recent Development
Table 105. Harbin Pacific Biopharmaceutical Corporation Information
Table 106. Harbin Pacific Biopharmaceutical Description and Business Overview
Table 107. Harbin Pacific Biopharmaceutical Human Fibrinogen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Harbin Pacific Biopharmaceutical Human Fibrinogen Product
Table 109. Harbin Pacific Biopharmaceutical Recent Development
Table 110. Greencross Corporation Information
Table 111. Greencross Description and Business Overview
Table 112. Greencross Human Fibrinogen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Greencross Human Fibrinogen Product
Table 114. Greencross Recent Development
Table . Shanghai XinXing Medical Corporation Information
Table . Shanghai XinXing Medical Human Fibrinogen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Shanghai XinXing Medical Description and Business Overview
Table . Shanghai XinXing Medical Human Fibrinogen Product
Table . Shanghai XinXing Medical Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Human Fibrinogen Distributors List
Table 123. Human Fibrinogen Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Fibrinogen Product Picture
Figure 2. Global Human Fibrinogen Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Fibrinogen Market Share by Application in 2020 & 2026
Figure 6. Congenital Fibrinogen Deficiency Examples
Figure 7. Surgical Procedures Examples
Figure 8. Global Human Fibrinogen Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Human Fibrinogen Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Human Fibrinogen Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 11. Global Human Fibrinogen Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Human Fibrinogen Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Human Fibrinogen Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Human Fibrinogen Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Human Fibrinogen Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Human Fibrinogen Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Human Fibrinogen Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Human Fibrinogen Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Human Fibrinogen Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Human Fibrinogen Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Human Fibrinogen Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Human Fibrinogen Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Human Fibrinogen Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Human Fibrinogen Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Human Fibrinogen Players Market Share by Revenue in Human Fibrinogen 2015 & 2019
Figure 26. Human Fibrinogen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Human Fibrinogen Revenue Share by Type (2015-2020)
Figure 28. Global Human Fibrinogen Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Human Fibrinogen Revenue Share by Application (2015-2020)
Figure 30. Global Human Fibrinogen Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Human Fibrinogen Sales Market Share by Type in 2019
Figure 32. United States Human Fibrinogen Sales Market Share by Type in 2019
Figure 33. Europe Human Fibrinogen Sales Market Share by Company in 2019
Figure 34. Europe Human Fibrinogen Sales Market Share by Type in 2019
Figure 35. Europe Human Fibrinogen Sales Market Share by Application in 2019
Figure 36. China Human Fibrinogen Sales Market Share by Company in 2019
Figure 37. China Human Fibrinogen Sales Market Share by Type in 2019
Figure 38. China Human Fibrinogen Sales Market Share by Application in 2019
Figure 39. Japan Human Fibrinogen Sales Market Share by Company in 2019
Figure 40. Japan Human Fibrinogen Sales Market Share by Type in 2019
Figure 41. Japan Human Fibrinogen Sales Market Share by Application in 2019
Figure 42. Southeast Asia Human Fibrinogen Sales Market Share by Company in 2019
Figure 43. Southeast Asia Human Fibrinogen Sales Market Share by Type in 2019
Figure 44. Southeast Asia Human Fibrinogen Sales Market Share by Application in 2019
Figure 45. India Human Fibrinogen Sales Market Share by Company in 2019
Figure 46. India Human Fibrinogen Sales Market Share by Type in 2019
Figure 47. India Human Fibrinogen Sales Market Share by Application in 2019
Figure 48. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. LFB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Shanghai RAAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Boya Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Hualan Biological Engineering Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Harbin Pacific Biopharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Greencross Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Shanghai XinXing Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Human Fibrinogen
Figure 58. Manufacturing Process Analysis of Human Fibrinogen
Figure 59. Human Fibrinogen Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
フィブリノーゲン欠乏症薬の世界市場レポート2020 Market Analysis and Insights: Global Fibrinogen Deficiency Drug Market The global Fibrinogen Deficiency Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Fibrinogen Deficiency Drug Scope and Market Siz…- ヒトエンドスタチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Endostatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Endostatin market repo…
- ヒトプロトロンビン複合体の世界市場レポート2020 Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. The global average price of Hum…
- ヒト成長ホルモンの世界市場レポート2020 Market Analysis and Insights: Global Human Somatotropin Market The global Human Somatotropin market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Human Somatotropin Scope and Market Size The global Human Somat…
- 組換えヒトエンドスタチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Human Endostatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant Huma…